SCHEMBL4840110

SCHEMBL4840110

COc1ccc2c(c1)CC(C)(C)NC2=CC(=O)c1ccccc1OC

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.48
LMNA P02545 1/20 0.48
ALDH1A1 P00352 4/20 0.46
CYP1A2 P05177 2/20 0.46
CYP2D6 P10635 2/20 0.46
CYP2C9 P11712 2/20 0.46
HPGD P15428 2/20 0.46
CYP2C19 P33261 2/20 0.46
GAA P10253 2/20 0.46
CYP3A4 P08684 1/20 0.46
MAPT P10636 7/20 0.46
HTT P42858 2/20 0.46
NTSR1 P30989 1/20 0.45
KMT2A Q03164 5/20 0.45
MAPK1 P28482 4/20 0.45
MEN1 O00255 3/20 0.45
PKM P14618 1/20 0.45
CASP1 P29466 1/20 0.45
CASP7 P55210 1/20 0.45
NPSR1 Q6W5P4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4840105 1.00 KDM4E (0.48) KDM4ELMNAALDH1A1CYP1A2CYP2D6
SCHEMBL4835816 0.92 KDM4E (0.48) KDM4ELMNAALDH1A1CYP1A2CYP2D6
SCHEMBL4835807 0.92 KDM4E (0.48) KDM4ELMNAALDH1A1CYP1A2CYP2D6
SCHEMBL6391035 0.89 LMNA (0.48) KDM4ELMNAALDH1A1CYP1A2CYP2D6
SCHEMBL6391041 0.89 LMNA (0.48) KDM4ELMNAALDH1A1CYP1A2CYP2D6
SCHEMBL4844186 0.88 KDM4E (0.47) KDM4ELMNAALDH1A1CYP1A2CYP2D6
SCHEMBL4844200 0.88 KDM4E (0.47) KDM4ELMNAALDH1A1CYP1A2CYP2D6
SCHEMBL4843566 0.88 KDM4E (0.47) KDM4ELMNAALDH1A1CYP1A2CYP2D6
SCHEMBL4843574 0.88 KDM4E (0.47) KDM4ELMNAALDH1A1CYP1A2CYP2D6
SCHEMBL4846014 0.88 KDM4E (0.62) KDM4ELMNAALDH1A1CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2005-10-06 US claimed
US-7378428-B2 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2008-05-27 US disclosed
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2005-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient PARK7, MMP8, CDK7 KDM4E 4466/4885LMNA 3014/4885ALDH1A1 2636/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.